(A) Schematic diagram of the RS (2 hr/day) application for 2 weeks, followed by 1 day each for the OFT, TST, and FST before fixation, or by fixation for c-Fos staining. (B–D) Immobility time in the …
p Values and statistical tests related to Figure 1.
Effect sizes for behavior results related to Figure 1.
(A) Examples of movement traces from the CTR and RS groups during 30 min of the OFT. (B) Measurement of the time spent in the center zone or the peripheral zone in the OFT. Data are presented as …
Images of DN-containing cerebellar slices co-stained for NeuN (A), GAD67 (B), or GFAP (C) and c-Fos with DAPI. Most of c-Fos-positive cells are NeuN-positive cells, as seen in (A). Yellow arrowheads …
(A) Top: a schematic of AAV-sSyn-FLEX-hM3Dq-2AGFP injection into crus I of PCP2-Cre mice. Bottom: confocal image of a whole cerebellar slice showing the expression of Gq-2AGFP. Scale bar: 500 μm. (B)…
p Values and statistical tests related to Figure 2.
Effect sizes for behavior results related to Figure 2.
Numbers of mice for each sex used in each behavioral test related to Figure 2.
(A, B, C) Effects of unilateral excitation of crus I PC activity in PCP2-Cre;ICR mice in the TST (A), the FST (B) and the OFT (C). (D, E, F) Effects of bilateral excitation of crus I PC activity in …
Comparisons of body weight changes in mice used for Figure 2G–I (A) and Figure 2J–L (B). *** < 0.001, one-way ANOVA followed by the Fisher’s LSD post hoc test. Data are shown as the mean ± SEM.
(A–C) Left: schematic drawing of AAV-sSyn-GFP injection into the right side of the FN (A), the IPN (B), and the DN (C). Note that iontophoretic injection was used, to achieve confined injection of …
(A–C) Screening of GFP-positive axons in the whole VTA (bottom) followed by an iontophoretic injection of AAV-sSyn-GFP into the FN (A), the IPN (B), or the DN (C). Scale bar: 500 μm.
(A) Left: schematic drawing of the injection of AAV-sSyn-ChR2-GFP or AAV-sSyn-ChR2-2AdT into the DN, for whole-cell patch clamp recording from VTA neurons. Right: confocal images of ChR2-2AdT …
p Values and statistical tests related to Figure 4.
(A) A trace of EPSCs (top) evoked by 50 Hz photostimulation at a holding potential of −70 mV, and Ih currents (bottom) recorded in the same VTA neuron by applying voltage steps varying from −70 mV …
(A and B) Representative images of a midbrain slice (left) and a cerebellar slice (right) in (A). In the left panel, the area within the white dotted square is magnified in (B), and dotted lines in …
p Values and statistical tests related to Figure 5.
(A) Screening of GFP-positive collateral axons of VTA-projecting DCN neurons in the whole cerebellar cortex, following double injections into the DCN and the VTA, as shown at the top. The …
(A) Diagram of combined AAV injection. Bilateral injections of AAV-sSyn-tdT and AAV-sSyn-FLEX-hM4Di(Gi)–2AGFP was carried out into the DCN and a mixture of AAV-sSyn-mTBFP and retroAAV-CAG-Cre was …
p Values and statistical tests related to Figure 6.
Effect sizes for behavior results related to Figure 6.
Numbers of mice for each sex used in each behavioral test related to Figure 6.
Comparisons of body weight changes in mice used for Figure 6B–D (A) and Figure 6E–G (B). ** < 0.01, *** < 0.001, one-way ANOVA followed by the Fisher’s LSD post hoc test. Data are shown as the mean …
(A and E) Diagram of the experimental time course to check the effects of the excitation of VTA-projecting DCN neurons alone on depression-like behaviors. The OFT, TST, and FST were performed after …
p Values and statistical tests related to Figure 7.
Effect sizes for behavior results related to Figure 7.
Numbers of mice for each sex used in each behavioral test related to Figure 7.
(A) Diagram of combined AAV injection. Bilateral injections of AAV-sSyn-tdT and AAV-sSyn-FLEX-hM3Dq(Gq)–2AGFP was carried out into the DCN and a mixture of AAV-sSyn-mTBFP and retroAAV-CAG-Cre was …
Comparisons of body weight changes in mice used for Figure 7—figure supplement 1B–D (A), Figure 7—figure supplement 1E–G (B), Figure 7B–D (C) and Figure 7F–J and Figure 7—figure supplement 1H (D). …
The correlation was calculated from data of all mice used in each series of experiments for Figure 2J–L, Figure 6B–D, or Figure 7B–D.
Figure | Test | Sample numbers | Comparison | Coefficient (r) | p value | Significance |
---|---|---|---|---|---|---|
Figure 2J-L | Effects of excitation of crus I PCs on RS | 119 | TST vs FST | 0.464 | 1.17 × 10–7 | *** |
TST vs OFT | 0.153 | 0.0961 | ||||
FST vs OFT | 0.0303 | 0.743 | ||||
Figure 6B-D | Effects of inhibition of VTA-projecting DCN neurons on RS | 116 | TST vs FST | 0.327 | 3.42 × 10–4 | *** |
TST vs OFT | –0.119 | 0.204 | ||||
FST vs OFT | 0.0474 | 0.0613 | ||||
Figure 7B-D | Only excitation of VTA-projecting DCN neurons | 70 | TST vs FST | 0.439 | 1.43 × 10–4 | *** |
TST vs OFT | –0.0308 | 0.8 | ||||
FST vs OFT | –0.0143 | 0.907 |
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C57BL/6 J mice | Orient Bio | N/A | |
Strain, strain background (Mus musculus) | ICR mice; CrljOri:CD1 | Orient Bio | N/A | |
Genetic reagent (Mus musculus) | Gad2-IRES-Cre mice; Gad2tm2(cre)Zjh/J | Jackson Laboratories | Stock No: 010802; RRID:IMSR_JAX:010802 | |
Genetic reagent (Mus musculus) | Pcp2-cre mice; B6.129-Tg(Pcp2-cre)2Mppin/J | Jackson Laboratories | Stock No: 004146; RRID:IMSR_JAX:004146 | |
Genetic reagent (Mus musculus) | Ai six reporter mice; B6.Cg-Gt(ROSA)26Sortm6(CAG-ZsGreen1)Hze/J | Jackson Laboratories | Stock No: 007906; RRID:IMSR_JAX:007906 | |
Antibody | Mouse monoclonal anti-calbindin | Sigma-Aldrich | Cat#C9848; RRID:AB_476894 | (1:200) |
Antibody | Rabbit polyclonal anti-TH | Millipore | Cat#AB152; RRID: AB_390204 | (1:400) |
Antibody | Rabbit monoclonal anti-c-Fos | Cell Signalling Technology | Cat#2250; RRID: AB_2247211 | (1:300) |
Antibody | Mouse monoclonal anti-NeuN | Millipore | Cat#MAB377; RRID: AB_2298772 | (1:200) |
Antibody | Mouse monoclonal anti-GAD67 | Millipore | Cat#MAB5406; RRID:AB_2278725 | (1:1000) |
Antibody | Mouse monoclonal anti-GFAP | Millipore | Cat#MAB360; RRID:11212597 | (1:200) |
Antibody | Goat anti-mouse IgG(H + L) alexa fluor@647 | Invitrogen | Cat#A21235; RRID: AB_2535804 | (1:200) |
Antibody | Goat anti-rabbit IgG(H + L) alexa fluor@647 | Invitrogen | Cat#A21245; RRID: AB_141775 | (1:200) |
Antibody | Rabbit polyclonal anti-OLLAS | Antibodies-online | ABIN1842163 | (1:1000) |
Chemical compound, drug | Clozapine N-oxide | Hello Bio | Cat#HB1807 | 10 mg/kg, i.p. |
Chemical compound, drug | Bicuculline methochloride | Tocris Bioscience | Cat#0131 | |
Chemical compound, drug | Mounting medium | Vector Laboratories | Cat#H-1400 | |
Chemical compound, drug | Mounting medium with DAPI | Vector Laboratories | Cat#H-1500 | |
Chemical compound, drug | Prolong diamond antifade mountant | Thermo Fisher Scientific | Cat#P36961 | |
Chemical compound, drug | Cholera toxin subunit B, Alexa flour 647 conjugate | Thermo Fisher Scientific | Cat#C34778 | |
Chemical compound, drug | Tetrodotoxin | Tocris Bioscience | Cat#1,069 | |
Chemical compound, drug | 4-Aminopyridine | Tocris Bioscience | Cat#0940 | |
Recombinant DNA reagent | pAAV-hSyn-DIO-hM3Dq(Gq)-mCherry | Addgene | Addgene plasmid #44,361 | |
Recombinant DNA reagent | pAAV-hSyn-DIO-hM4Di(Gi)-mCherry | Addgene | Addgene plasmid #44,362 | |
Recombinant DNA reagent | pAAV-CaMKIIa-hChR2(H134R)-EYFP | Addgene | Addgene plasmid #26,969 | |
Recombinant DNA reagent | AAV-CaMKIIa- GCaMP6f-P2A-nls-dTomato | Addgene | Addgene plasmid #51,087 | |
Recombinant DNA reagent | pBAD-mTagBFP2 | Addgene | Addgene plasmid #34,632 | |
Recombinant DNA reagent | ptdTomato-N1 | Clontech | Cat#632,532 | |
Recombinant DNA reagent | paavCAG-iCre | Addgene | Addgene plasmid #51,904 | |
Recombinant DNA reagent | paavCAG-sfGFP | Addgene | Will be deposited | |
Recombinant DNA reagent | paavCAG-pre- mGRASPi- mCerulean | Addgene | Will be deposited | |
Recombinant DNA reagent | paavCAG-post-mGRASPi-2AdT | Addgene | Addgene plasmid #34,912 | |
Recombinant DNA reagent | rAAV2-retro helper | Addgene | Addgene plasmid #81,070 | |
Biological sample (AAV) | AAV-sSyn-GFP | Kim et al., Kim et al., 2015a | ||
Biological sample (AAV) | AAV-sSyn-tdT | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-mTBFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-ChR2-GFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-ChR2-2AdT | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-FLEX-GFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-FLEX-ChR2-GFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-FLEX-hM3Dq(Gq)–2AGFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Biological sample (AAV) | AAV-sSyn-FLEX-hM4Di(Gi)–2AGFP | This paper | Further information will be provided by the Lead Contact upon request. | |
Software, algorithm | pClamp 10 | Axon instruments | RRID:SCR_011323 | |
Software, algorithm | NIS-Element | Nikon | RRID:SCR_014329 | |
Software, algorithm | Fiji | NIH | RRID:SCR_002285 | |
Software, algorithm | Ethovision | Noldus | RRID:SCR_000441 | |
Software, algorithm | Origin | Origin Lab | RRID:SCR_014212 |
RS duration | DCN sub-region | Control | Stress | RS-Gq-CNO | ||||||
---|---|---|---|---|---|---|---|---|---|---|
DAPI | c-Fos | N | DAPI | c-Fos | N | DAPI | c-Fos | N | ||
3 day | DN | 94.6 ± 8 | 31.4 ± 4.2 | 5 | 97.2 ± 28.5 | 50.8 ± 14.6 | 5 | - | - | - |
7 day | DN | 152 ± 15 | 41.8 ± 14.2 | 5 | 152 ± 21.7 | 96.4 ± 20.2 | 5 | - | - | - |
10 day | DN | 128.2 ± 18.7 | 32.6 ± 8.7 | 5 | 119.6 ± 20.3 | 67 ± 11.2 | 5 | - | - | - |
14 day | DN | 147.6 ± 46.5 | 36.4 ± 12.9 | 8 | 109.3 ± 53.9 | 54.8 ± 22.3 | 8 | 95.8 ± 11.1 | 21.4 ± 10.7 | 5 |
IPN | 114.3 ± 30.5 | 35.5 ± 9.5 | 8 | 99.6 ± 32 | 47 ± 24 | 8 | - | - | - | |
FN | 103.8 ± 29 | 35.5 ± 9.9 | 8 | 112.1 ± 33.2 | 47.5 ± 21 | 8 | - | - | - |